Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.57 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.57 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | LCK | P06239 | 1/20 | 0.55 |
| ▸ | PPARD | Q03181 | 1/20 | 0.55 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.55 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.47 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.47 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL42984 | 1.00 | GPR84 (0.57) | GPR84FFAR1ACE2MAPTLCK | |
| SCHEMBL1131472 | 1.00 | GPR84 (0.57) | GPR84FFAR1ACE2MAPTLCK | |
| SCHEMBL9216782 | 1.00 | GPR84 (0.57) | GPR84FFAR1ACE2MAPTLCK | |
| SCHEMBL10786248 | 1.00 | GPR84 (0.57) | GPR84FFAR1ACE2MAPTLCK | |
| SCHEMBL2830699 | 1.00 | GPR84 (0.57) | GPR84FFAR1ACE2MAPTLCK | |
| SCHEMBL2829338 | 1.00 | GPR84 (0.57) | GPR84FFAR1ACE2MAPTLCK | |
| SCHEMBL635007 | 1.00 | GPR84 (0.57) | GPR84FFAR1ACE2MAPTLCK | |
| SCHEMBL26421 | 1.00 | GPR84 (0.57) | GPR84FFAR1ACE2MAPTLCK | |
| SCHEMBL503120 | 1.00 | GPR84 (0.57) | GPR84FFAR1ACE2MAPTLCK | |
| SCHEMBL63654 | 1.00 | GPR84 (0.57) | GPR84FFAR1ACE2MAPTLCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100322877-A1 | SILICONE ELASTOMERS IN COSMETIC ESTERS | ALZO INTERNATIONAL, INC. | 2010-12-23 | — | — | US | claimed |
| EP-2211833-A2 | SILICONE ELASTOMERS IN COSMETIC ESTERS | Alzo International, Inc. (US) | 2010-08-04 | — | — | EP | claimed |
| WO-2009054931-A2 | SILICONE ELASTOMERS IN COSMETIC ESTERS | ALZO INTERNATIONAL, INC. (US) | 2009-04-30 | — | — | WO | claimed |
| WO-2024262346-A1 | VULCANIZING AGENT COMPOSITION AND PRODUCTION METHOD FOR SAME, RUBBER COMPOSITION AND PRODUCTION METHOD FOR SAME, AND VULCANIZED RUBBER AND PRODUCTION METHOD FOR SAME | 四国化成工業株式会社 | 2024-12-26 | — | — | WO | disclosed |
| CN-111096926-B | Cosmetic composition comprising as active ingredient a linear emulsifier and a pigment having a coating on the surface | 株式会社爱茉莉太平洋 | 2023-08-25 | — | — | CN | disclosed |
| CN-111096926-A | Cosmetic composition for makeup containing linear emulsifier as active ingredient and pigment with coating layer on surface | 株式会社爱茉莉太平洋 | 2020-05-05 | — | — | CN | disclosed |
| WO-2015048228-A2 | IMPROVED SILICONE ELASTOMER GELS AND RELATED HYDROSILYLATION PROCESSES | ALZO INTERNATIONAL, INC. (US) | 2015-04-02 | — | — | WO | disclosed |
| EP-2654665-A2 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY | MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH (DE) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012135281-A2 | SILICONE CROSSLINKED UNSATURATED HYDROCARBON BASED POLYMERS | ALZO INTERNATIONAL, INC. (US) | 2012-10-04 | — | — | WO | disclosed |
| WO-2012083906-A2 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY | MIKA PHARMA GESELLSCHAFT FÜR DIE ENTWICKLUNG UND VERMARKTUNG PHARMAZEUTISCHER PRODUKTE MBH (DE) | 2012-06-28 | — | — | WO | disclosed |
| US-20100322877-A1 | SILICONE ELASTOMERS IN COSMETIC ESTERS | ALZO INTERNATIONAL, INC. | 2010-12-23 | — | — | US | disclosed |
| US-7687483-B2 | Derivatives of branch-chain lipophilic molecular and uses thereof | D-PHARM LTD. (IL) | 2010-03-30 | — | — | US | disclosed |
| EP-1305322-B1 | DERIVATIVES OF BRANCHED-CHAIN LIPOPHILIC MOLECULES AND USES THEREOF | DPHARM LTD (IL) | 2010-01-13 | — | — | EP | disclosed |
| WO-2009054931-A2 | SILICONE ELASTOMERS IN COSMETIC ESTERS | ALZO INTERNATIONAL, INC. (US) | 2009-04-30 | — | — | WO | disclosed |
| US-20070135381-A1 | Derivatives of branch-chain lipophilic molecular and uses thereof | D-PHARM LTD. (IL) | 2007-06-14 | — | — | US | disclosed |
| US-7186703-B2 | Derivatives of branched-chain lipophilic molecules and uses thereof | D-PHARM LTD. (IL) | 2007-03-06 | — | — | US | disclosed |
| EP-1305322-A4 | DERIVATIVES OF BRANCHED-CHAIN LIPOPHILIC MOLECULES AND USES THEREOF | DPHARM LTD (IL) | 2005-04-13 | — | — | EP | disclosed |
| US-20030186897-A1 | Derivatives of branched-chain lipophilic molecules and uses thereof | D-PHARM, LTD. (IL) | 2003-10-02 | — | — | US | disclosed |
| EP-1305322-A2 | DERIVATIVES OF BRANCHED-CHAIN LIPOPHILIC MOLECULES AND USES THEREOF | D-Pharm Ltd. (IL) | 2003-05-02 | — | — | EP | disclosed |
| WO-2002011666-A2 | DERIVATIVES OF BRANCHED-CHAIN LIPOPHILIC MOLECULES AND USES THEREOF | D-PHARM LTD. (IL) | 2002-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135381-A1 | Derivatives of branch-chain lipophilic molecular and uses thereof | PLIN3, GLS, LIPG | GPR84 1669/4885FFAR1 1070/4885ACE2 3374/4885 |
| US-20100322877-A1 | SILICONE ELASTOMERS IN COSMETIC ESTERS | CUTA, LAGE3, MMS19 | GPR84 1715/4885FFAR1 992/4885ACE2 4626/4885 |
| US-20030186897-A1 | Derivatives of branched-chain lipophilic molecules and uses thereof | PLIN3, PLIN5, SLC27A1 | GPR84 657/4885FFAR1 634/4885ACE2 2146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.